Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials
Publication
, Conference
Marx, C; Naylor, J; Kilts, J; Szabo, S; Wagner, R; Parke, G; Morey, R; Grant, G; Hauser, M; Stein, M; Shampine, L
Published in: NEUROPSYCHOPHARMACOLOGY
November 1, 2017
Duke Scholars
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
November 1, 2017
Volume
42
Start / End Page
S404 / S404
Location
Palm Springs, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP) and Cognitive-Neuroscience-Society
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Marx, C., Naylor, J., Kilts, J., Szabo, S., Wagner, R., Parke, G., … Shampine, L. (2017). Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials. In NEUROPSYCHOPHARMACOLOGY (Vol. 42, pp. S404–S404). Palm Springs, CA: NATURE PUBLISHING GROUP.
Marx, Chris, Jennifer Naylor, Jason Kilts, Steven Szabo, Ryan Wagner, Gillian Parke, Rajendra Morey, et al. “Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials.” In NEUROPSYCHOPHARMACOLOGY, 42:S404–S404. NATURE PUBLISHING GROUP, 2017.
Marx C, Naylor J, Kilts J, Szabo S, Wagner R, Parke G, et al. Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials. In: NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP; 2017. p. S404–S404.
Marx, Chris, et al. “Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials.” NEUROPSYCHOPHARMACOLOGY, vol. 42, NATURE PUBLISHING GROUP, 2017, pp. S404–S404.
Marx C, Naylor J, Kilts J, Szabo S, Wagner R, Parke G, Morey R, Grant G, Hauser M, Stein M, Shampine L. Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials. NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP; 2017. p. S404–S404.
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
November 1, 2017
Volume
42
Start / End Page
S404 / S404
Location
Palm Springs, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP) and Cognitive-Neuroscience-Society
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences